This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Sep 6;372(9641):803; author reply 804-5.

doi: 10.1016/S0140-6736(08)61330-6.

Abacavir and increased risk of myocardial infarction

Frank A Post, Lucy J Campbell

PMID: 18774412
DOI: 10.1016/S0140-6736(08)61330-6

Comment

Abacavir and increased risk of myocardial infarction

Frank A Post et al. Lancet. 2008.

. 2008 Sep 6;372(9641):803; author reply 804-5.

doi: 10.1016/S0140-6736(08)61330-6.

Authors

Frank A Post, Lucy J Campbell

PMID: 18774412
DOI: 10.1016/S0140-6736(08)61330-6

No abstract available

PubMed Disclaimer

Comment on

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.
D:A:D Study Group; Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Møller N, Kirk O, Pradier C, Weller I, Phillips AN, Lundgren JD. D:A:D Study Group, et al. Lancet. 2008 Apr 26;371(9622):1417-26. doi: 10.1016/S0140-6736(08)60423-7. Epub 2008 Apr 2. Lancet. 2008. PMID: 18387667 Free PMC article.

Similar articles

Abacavir and the potential risk of myocardial infarction.
Cutrell A, Brothers C, Yeo J, Hernandez J, Lapierre D. Cutrell A, et al. Lancet. 2008 Apr 26;371(9622):1413. doi: 10.1016/S0140-6736(08)60492-4. Epub 2008 Apr 2. Lancet. 2008. PMID: 18387668 No abstract available.
Abacavir and increased risk of myocardial infarction.
Goicoechea M, McCutchan A. Goicoechea M, et al. Lancet. 2008 Sep 6;372(9641):803-4; author reply 804-5. doi: 10.1016/S0140-6736(08)61331-8. Lancet. 2008. PMID: 18774413 No abstract available.
Use of Abacavir and Risk of Cardiovascular Disease Among HIV-Infected Individuals.
Marcus JL, Neugebauer RS, Leyden WA, Chao CR, Xu L, Quesenberry CP Jr, Klein DB, Towner WJ, Horberg MA, Silverberg MJ. Marcus JL, et al. J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):413-9. doi: 10.1097/QAI.0000000000000881. J Acquir Immune Defic Syndr. 2016. PMID: 26536316
Abacavir and cardiovascular disease: A critical look at the data.
Llibre JM, Hill A. Llibre JM, et al. Antiviral Res. 2016 Aug;132:116-21. doi: 10.1016/j.antiviral.2016.05.015. Epub 2016 May 31. Antiviral Res. 2016. PMID: 27260856 Review.
A review of abacavir and efavirenz: new antiretroviral drugs to treat HIV-1 infection.
Wolbach J, Capoccia K. Wolbach J, et al. Nurse Pract. 1999 Jun;24(6):81-2, 87-90, 92. Nurse Pract. 1999. PMID: 10431297 Review. No abstract available.

See all similar articles

Cited by

Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now?
Martin-Iguacel R, Llibre JM, Friis-Moller N. Martin-Iguacel R, et al. Curr HIV/AIDS Rep. 2015 Dec;12(4):375-87. doi: 10.1007/s11904-015-0284-6. Curr HIV/AIDS Rep. 2015. PMID: 26423407 Review.
Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration.
Sabin CA, Reiss P, Ryom L, Phillips AN, Weber R, Law M, Fontas E, Mocroft A, de Wit S, Smith C, Dabis F, d'Arminio Monforte A, El-Sadr W, Lundgren JD; D:A:D Study Group. Sabin CA, et al. BMC Med. 2016 Mar 31;14:61. doi: 10.1186/s12916-016-0588-4. BMC Med. 2016. PMID: 27036962 Free PMC article.
Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV.
Achenbach CJ, Scarsi KK, Murphy RL. Achenbach CJ, et al. Adv Ther. 2010 Jan;27(1):1-16. doi: 10.1007/s12325-010-0006-9. Epub 2010 Mar 5. Adv Ther. 2010. PMID: 20204580 Free PMC article. Review.
Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort.
Davies Smith E, Malvestutto C, Ribaudo HJ, Fichtenbaum CJ, Aberg JA, Watanabe M, Bloomfield GS, Currier JS, Chu SM, Fitch KV, Diggs MR, Bedimo R, Valencia J, Gomez-Ayerbe C, Brar I, Madruga JV, Lu MT, Douglas PS, Zanni MV, Grinspoon SK. Davies Smith E, et al. Open Forum Infect Dis. 2025 Mar 21;12(4):ofaf177. doi: 10.1093/ofid/ofaf177. eCollection 2025 Apr. Open Forum Infect Dis. 2025. PMID: 40207047 Free PMC article.
Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons.
Choi AI, Vittinghoff E, Deeks SG, Weekley CC, Li Y, Shlipak MG. Choi AI, et al. AIDS. 2011 Jun 19;25(10):1289-98. doi: 10.1097/QAD.0b013e328347fa16. AIDS. 2011. PMID: 21516027 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information